A carregar...
A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study
INTRODUCTION: In Japan, the age of patients with pancreatic cancer has increased. Combination chemotherapies such as 5-fluorouracil/leucovorin, oxaliplatin and irinotecan therapy and gemcitabine hydrochloride (GEM) +nab paclitaxel therapy have been developed as the standard treatments for young pati...
Na minha lista:
| Publicado no: | BMJ Open Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5841525/ https://ncbi.nlm.nih.gov/pubmed/29527313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2017-000187 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|